Oncobiologics Inc Debt to Equity Ratio (Quarterly)
Oncobiologics Inc Debt to Equity Ratio (Quarterly) Chart
Oncobiologics Inc Historical Debt to Equity Ratio (Quarterly) Data
There is no data for the selected date range.
An error occurred. Please try again by refreshing your browser or contact us with details of your problem.
About Debt to Equity Ratio
Leverage ratio indicating the relative proportion of shareholders' equity and debt used to finance a company's assets. A low debt to equity ratio indicates lower risk, because debt holders have less claims on the company's assets. A debt to equity ratio of 5 means that debt holders have a 5 times more claim on assets than equity holders.
A high debt to equity ratio usually means that a company has been aggressive in financing growth with debt and often results in volatile earnings.
It is also known as Debt/Equity Ratio, Debt-Equity Ratio, and D/E Ratio.
ONS Debt to Equity Ratio (Quarterly) Benchmarks
|Processa Pharmaceuticals Inc||Upgrade|
|Karyopharm Therapeutics Inc||Upgrade|
ONS Debt to Equity Ratio (Quarterly) Range, Past 5 Years
ONS Debt to Equity Ratio (Quarterly) Excel Add-In Codes
- Metric Code: debt_equity_ratio
- Latest data point: =YCP("ONS", "debt_equity_ratio")
- Last 5 data points: =YCS("ONS", "debt_equity_ratio", -4)
To find the codes for any of our financial metrics, see our Complete Reference of Metric Codes.
Access our powerful Excel Add-in with a YCharts Professional Membership. Learn More.
SA Breaking News 08/14 16:58 ET
Globe Newswire 08/14 16:15 ET
MT Newswires 08/02 08:26 ET
Globe Newswire 08/02 08:00 ET
MT Newswires 07/11 09:38 ET
Globe Newswire 07/11 09:00 ET
Globe Newswire 06/20 16:21 ET
MT Newswires 06/18 09:32 ET